Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.
about
Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Monitoring the responsiveness ...... e to neoadjuvant chemotherapy.
@en
Monitoring the responsiveness ...... e to neoadjuvant chemotherapy.
@nl
type
label
Monitoring the responsiveness ...... e to neoadjuvant chemotherapy.
@en
Monitoring the responsiveness ...... e to neoadjuvant chemotherapy.
@nl
prefLabel
Monitoring the responsiveness ...... e to neoadjuvant chemotherapy.
@en
Monitoring the responsiveness ...... e to neoadjuvant chemotherapy.
@nl
P2093
P2860
P1433
P1476
Monitoring the responsiveness ...... e to neoadjuvant chemotherapy.
@en
P2093
Carlos A Parra-López
David A Bernal-Estévez
Oscar García
Ramiro Sánchez
P2860
P2888
P356
10.1186/S12885-017-3982-1
P407
P577
2018-01-15T00:00:00Z
P6179
1100404915